Home

David Malcom Rodman, Chief Medical Officer: Mineralys Therapeutics MLYS Sell · Filed 23/08/11

Trade details

Type
Insider sale
Amount
$1,036,444.29
Shares · price
80,909 sh · $12.81 a share
Held after
0 sh
Trade date
23/08/11
Filed
23/08/11
Days to filing
0 days

Sold 100.0% of holdings

Share of holding sold
100.0%

Mineralys Therapeutics trades, last 26 weeks

What else happened in Mineralys Therapeutics around then

Filed or reported within 30 days of the trade day · 23/07/12~23/09/10

David Malcom Rodman's recent trades

  • David Malcom Rodman

    Planned sale10b5-1 planMineralys Therapeutics

    $11.7K

    Filed 09/17

  • David Malcom Rodman

    Planned sale10b5-1 planMineralys Therapeutics

    $216.9K

    Filed 09/14

  • David Malcom Rodman

    Planned sale10b5-1 planMineralys Therapeutics

    $67K

    Filed 09/09

  • David Malcom Rodman

    Planned sale10b5-1 planMineralys Therapeutics

    $10.6K

    Filed 08/17

  • David Malcom Rodman

    Planned sale10b5-1 planMineralys Therapeutics

    $372.2K

    Filed 08/13

David Malcom Rodman, Chief Officer — sold $1M of Mineralys Therapeutics MLYS · 100.0% of holdings | Whalegun